CYP3A4 is an important CYP enzyme, responsible for clearing approximately 45 – 60% of currently prescribed drugs. Different supplements, food components, and drugs can change CYP3A4 activity and, as a result, interfere with drug metabolism. Find out more about its function, gene variants, and factors that decrease/increase CYP3A4 activity.
What is CYP3A4?
CYP3A4 is one of the cytochrome P450 monooxygenases (CYPs), which are enzymes that eliminate most of the drugs and toxins from our body .
This enzyme is one of the most important CYP enzymes since it is responsible for processing approximately 45–60% of prescribed drugs [2, 3]:
- Opioids: sufentanil  and methadone 
- Immunosuppressants: cyclosporine , tacrolimus , and sirolimus 
- Antihypertensive drugs: felodipine  and nifedipine 
- Anticancer drugs: endoxifen , tamoxifen , and sunitinib 
- Sedatives: midazolam 
- Cholesterol-lowering drugs (statins): simvastatin , atorvastatin, and lovastatin 
- Antibiotics: erythromycin 
- Corticosteroids: fluticasone propionate 
- Metabolizes many internal compounds such as cholesterol, fatty acids, prostaglandins, leukotrienes, retinoids and biogenic amines .
- Detoxifies bile acids .
- Deactivates testosterone to biologically less active metabolites .
- Partly degrades vitamin D .
This enzyme degrades the majority of drugs and cancer-causing agents, to protect cells and the body from toxins [10, 12].
The activity of this enzyme varies up to 40-fold and is affected by health, environment (smoking, diet, and co-medication), hormones, and genetics .
Nuclear receptors PXR and CAR activate CYP3A4 .
This enzyme is mainly found in the liver (∼40% of the total liver CYP content) but also in the small intestine, prostate, breast, colon, and brain [7, 6, 4, 3].
CYP3A4 is the most active CYP enzyme in the gut . Therefore it is not surprising that what we eat and drink has a great effect on the activity of this enzyme.
Components in foods, drinks, food additives, and other drugs usually decrease CYP3A4 activity producing one of the following effects:
- Inhibiting the inactivation or degradation of the drug and thus increasing the actual dose of the active form in the blood, which often causes unfavorable and long-lasting effects .
- Inhibiting the activation of some medications that are administered as pro-drugs and thus decreasing the actual dose of the active form of the drug that reaches the blood; this lowers the efficacy of the drug .
Factors That Impact CYP3A4 Activity
Factors That Increase CYP3A4
- St. John’s wort [14, 15, 16]
- Capsaicin [17, 18]
- Common valerian 
- Echinacea purpurea 
- Vitamin D and UV exposure 
- Being female 
- Diabetes 
- Fatty acids 
- Polycyclic aromatic hydrocarbons (PAH) found in cigarettes 
- Aflatoxin B1 
- Some drugs such as carbamazepine  and dexamethasone 
Factors That Decrease CYP3A4
- Grapefruit juice (and its compounds bergamottin, naringenin, and paradicin-A) [26, 4, 27]
- Starfruit juice 
- Aloe vera juice 
- Mixed vegetable juices 
- Kale 
- Garden cress [32, 33]
- Fennel 
- Green tea [4, 35]
- Black pepper [36, 37]
- Goldenseal 
- Raspberry leaf 
- Milk thistle (compounds silybin and isosilybin) 
Supplements and Isolated Compounds
- Quercetin [40, 41, 42]
- Kaempferol 
- Berberine [43, 44]
- Piperine (a constituent of black pepper) [36, 37]
- Licochalcone A, a compound in traditional Chinese herbal licorice 
- Oleuropein, derived from olive oil 
- Sesamin, found in sesame seeds (Sesamum indicum) 
- Resveratrol [33, 47, 4]
- Sulforaphane 
- Apigenin 
- Coumestrol 
- Caffeic acid [41, 4]
- Tannic acid 
- Gallic acid [4, 50]
- Allyl isothiocyanate 
- Ginsenoside Rd , derived from Ginseng
- Gomisin C and gomisin G found in the traditional Chinese medicine Schisandra Chinensis 
- Green tea flavonols EGCG and epicatechin gallate [4, 35]
- Ritonavir, itraconazole 
- Miconazole, ketoconazole 
- Verapamil 
- Sertraline 
- Metformin 
- Nefazodone 
- Clarithromycin 
Curcumin has a paradoxical effect, since it both increases and decreases the activity of CYP3A4 [61, 62, 63].
CYP3A4 Genetic Variants
It’s important to note that just because certain genotypes are associated with a condition or irregular lab marker, it doesn’t necessarily mean that everyone with that genotype will actually develop the condition.
Unlike variable enzymes such as CYP2D6, CYP2C9 or CYP2C19, the CYP3A4 enzyme has fewer gene variants, and only a few of them are known to influence enzyme function .
Most of the SNPs (around 20) found in this enzyme have no functional significance .
Also known as CYP3A4*22 (T), rs35599367 is associated with decreased enzyme activity .
It is found in 4-8% of the population [7, 5].
T/T people have around 2 times lower enzyme activity .
People with this variant may require a 40% lower dose of simvastatin (830 subjects) .
Children on fluticasone propionate with CYP3A4*22 have improved asthma control (734 patients) .
CYP3A4*22 carriers were less likely to have severe hot flashes as side effects on tamoxifen therapy (132 patients) .
rs2740574 is frequent (50-82%) in Africans and African Americans, but rare (3-5%) in Whites . Functional significance is unknown.
It may be associated with methadone overdose and fatalities (228 cases) .
The G variant is associated with increased prostate cancer susceptibility ( a meta-analysis of 39 studies and over 30K participants) .
Individual carrying G have a 3 times greater risk of developing lung cancer (106 patients and 116 controls) .
This SNP is commonly found in Asians .
rs2242480 was associated with more frequent methadone overdose fatalities (228 cases) .
There is an association between the G variant of rs680055 and the probability of developing prostate cancer (240 patients and 223 controls) .